Background: Evidence has shown neurocognitive problems often exist among human immunodeficiency virus (HIV)-infected children. There are limited data for children in Nigeria. Methods: This was a cross-sectional study of 100 school-aged perinatally HIV-infected children seen in the paediatric HIV clinic and age/sex-matched controls from the general paediatric clinic. Neuro-cognitive functioning was assessed using the Raven's progressive matrices (RPM) that has been adapted for the Nigerian population. Results: The mean RPM score of subjects was 22.97 6 11.35 compared with 32.93 6 15.71 among controls (p < 0.001). Twenty-two percent of subjects in the HIV-infected group vs. 56% of controls were in the above-average intelligence group on the RPM. Thirty-four percent had average scores, while 22% were in the below-average scoring range. Neuro-cognitive functioning of the subjects was significantly affected by immunologic staging and socio-economic status. Conclusions: Neurocognitive functioning of the HIV-infected children was significantly lower than those of their un-infected counterparts. Neurodevelopmental evaluation should be part of standard care in HIV-infected children in Nigerian setting.
I N T R O D U C T I O N
The nervous system is among the most frequently and most seriously affected part in human immunodeficiency virus (HIV) infection. [1] The virus may directly infect various brain cells or cause indirect damage to the nervous system by the release of cytokines or reactive oxygen from HIV-infected lymphocytes or macrophages. [2] Neurologic and developmental abnormalities are important and frequent complications of HIV infection in children, particularly in younger perinatally infected children. [3, 4] Neurological and developmental signs can be early markers of HIV-1 disease in infants. [5] A wide range of central nervous system (CNS) manifestations of HIV disease has been reported and include cognitive and motor deficits, impaired brain growth and loss of developmental milestones. [6, 7] Cognitive delays in children may begin as early as 4 months, continue into the preschool years and manifest as either global or selective delays in V C The Author [2017] . Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com
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Journal of Tropical Pediatrics, 2017, 63, 425-430 doi: 10.1093/tropej/fmx006 Advance Access Publication Date: 20 February 2017 Original paper neurodevelopment at school age. [8] Cognitive deficits may either be directly related to the effects of HIV-1 on the brain during the first few years of life, which is the time of rapid brain development, or to the indirect effects of CNS infections or neoplasms secondary to an immunocompromised state. [9, 10] The frontal and parietal regions are responsible for higher cortical functions, and the destruction of their myelination process by HIV causes significant delay in higher functioning. [11] Cognitive assessment studies of HIV-infected children have been carried out in the USA, Europe and parts of Africa. [3, [11] [12] [13] [14] [15] Data from Nigeria are limited despite a large population of HIV-infected children.
Raven's progressive matrices (RPM) test is a widely used non-verbal test of general intelligence that appraises visuo-spatial reasoning, abstract thinking, deductive reasoning and general intelligence of individuals.
[16] The test was designed to minimize the influence of culture by relying on non-verbal problems that require abstract reasoning. [17] Currently, cognitive assessment has not been included in the routine care of HIV-infected children in developing countries such as Nigeria. It is crucial to ascertain the impact of HIV on the cognitive abilities of children with possible effect on their academic achievement. The study was aimed at assessing the cognitive function in school-aged HIVinfected children in Enugu using RPM test.
M E T H O D S

Study area
The study was conducted at the paediatric HIV clinic and the children's outpatient clinic, of the University of Nigeria Teaching Hospital, Ituku/Ozalla, Enugu.
Study population
The subjects were a series of stable HIV-infected children, 6-12 years, who came for their antiretroviral drug pick up at paediatric HIV clinic. The children had started highly active anti-retroviral treatment (HAART) at different ages depending on their clinical and immunological parameters. Our first-line anti-retroviral regimen is nevirapine, zidovudine and lamivudine. The controls were gender-and agedmatched apparently HIV un-infected children on follow-up visits at the paediatric out-patient clinics.
Inclusion criteria 1. Subjects were included if their HIV infection was through vertical transmission. These were HIVinfected children who were born to women with documented HIV infection during pregnancy or at delivery. HIV infection was subsequently diagnosed in such children through detection of viral markers (DNA polymerase chain reaction) or persistence of HIV antibodies after 18 months of life.
2. Controls were recruited if the child was HIVnegative and had no history suggesting meningitis, encephalitis, birth asphyxia or chronic disorders. Chronic disorders were defined as diseases that are slow in progression, long in duration, never cured and also require long-standing medical treatment.
[18] These conditions were excluded by taking relevant history from the caregivers.
Exclusion criteria
Children whose parents refused consent as well as those who refused to participate in the study.
Sample size determination
The minimum sample size for the study was calculated using the formula for comparison of two proportions.
The minimum calculated sample size for subjects and controls was 96 each.
Subject and control recruitment
There were 456 enrolled HIV-infected children during the study period of May 2013 to March 2014. A total of 203 were aged 6-15 years. Children aged 6-15 years that met the inclusion criteria were consecutively enrolled until desired sample size of 100 was achieved. Controls were drawn from the general paediatric clinic. A total of 600 children were attending the general paediatric clinic during the study period. One hundred sex-and age-matched controls were enrolled until the desired sample size of 100 was obtained.
A study proforma consisting of sociodemographic, clinical and relevant laboratory data was completed for each subject. The clinical and laboratory data on enrolment were used to determine the initial clinical and immunologic staging of the subjects, respectively. Immunologic staging was done using the CD4 count (cells per millimetre). It was further grouped into no suppression (>500), mild (350-499), advanced (200-349) and severe suppression (<200). The Oyedeji classification system [19] was used to determine the socio-economic status.
The study participants were assessed using the RPM cognitive test that has been adapted and validated for the Nigerian population. The RPM booklet containing a series of 60 matrices, in 5 sets of 12 each (A1-A12, B1-B12. . .E1-E12), a pattern of geometric shapes and an answer sheet was used. Each child was allowed enough time to complete the task. The parents/caregivers were not allowed to aid the children during the test. After completion of the task, the answers were marked using the marking scheme provided in the booklet, and the total number of correct responses were determined. The raw scores were checked against a scoring matrix table in the booklet to determine its correlate on the internationally norm percentile score. Each child was classified into any of the following categories according to the percentile score: 
Data analysis
The data collected were analysed using the Statistical Package for Social Sciences (SPSS) version 20.0 (SPSS Inc. Chicago, Illinois, USA). Descriptive statistics was used to summarize quantitative variables (such as age), while qualitative variables (such as socio-economic class) were summarized using proportions. Means were compared using Student's t test. The associations between categorical variables were analysed using logistic regression. Correlation was done using the Pearson's correlation coefficient and Spearman's correlation coefficient as appropriate. The level of significance was taken as p < 0.05.
R E S U L T S
A total of 200 children (100 subjects and 100 controls) were studied between May 2013 and March 2014. Their socio-demographic profile is shown in Table 1 . There were 46 males and 54 females (male:female ratio of 1:1.2). The median age of study participants was 10 years. The mean ages of subjects and controls were 9.96 61.82 and 9.98 6 1.85 years, respectively.
Clinical profile of the subjects
Of the 100 HIV-infected children, HIV diagnosis was made after 1 year of age in 95 (95%), while 54 (54%) were severely immunosuppressed at HIV diagnosis. Fourteen (14%) children were not eligible for HAART, while 25 (25%) had lost one or both parents to HIV disease as shown in Table 2 .
RPM scores
The RPM score according to age is shown in Table  3 . The overall mean RPM score for the HIV-positive children was 22.97 6 11.37 compared with 32.93 6 12.71 among the HIV-negative children (p ¼ 0.001).
RPM grading of study population Twenty-two percent of subjects in the HIV-infected group vs. 56% of controls were in the above-average intelligence group on the RPM. Thirty-four percent had average scores, while 22% were in the belowaverage scoring range (p <0.001).
Cognitive functioning and clinical/immunological staging Thirteen (23%) subjects in World Health Organization (WHO) stage 1 were of average and above-average intelligence, while five (11%) were of below-average intelligence. Two (4%) children in WHO clinical stage 4 were of average and aboveaverage intelligence, while seven (16%) were of below-average intelligence. Sixteen (66.7%) children with mild suppression were of average and aboveaverage intelligence compared with eight (33.3%) that were of below-average intelligence. Conversely, 33 (61.1%) children with severe suppression were of below-average intelligence compared with 21 (38.9%) who were of average and above-average intelligence (p < 0.001) as shown in Table 4 .
Cognitive functioning and HAART
Of the 86 HIV-positive children on HAART, 47 (54.65%) had cognitive performance of average and above, while 39 (45.35%) had below average. Nine of the 14 children that were ineligible for HAART were within and above average range, respectively, while 5 were of below average (p ¼ 0.5).
Cognitive functioning and socio-economic variables
All the children whose mothers had no formal education were of below-average intellectual capacity. Eighteen (87.5%) children in the upper socioeconomic class were of average and above-average intelligence. Fifteen (62.5%) children in the lower socio-economic class were of below-average intelligence, while nine (37.5%) were of average and above-average intelligence (p ¼ 0.004).
Regression analysis:
Regression analysis showed that socio-economic class (p ¼ 0.028) and immunologic stage (0.015) had significant negative effect on RPM scores of HIV-positive children.
D I S C U S S I O N
The lower cognitive functioning noted among the HIV-positive children compared with HIV-negative peers in the present study is similar to the reports of other studies that used RPM among school-aged HIV-positive children in Lagos, Nigeria, by Boyede et al. [20] and elsewhere. [21, 22] This reiterates the fact that HIV has a negative effect on the cognition of children and may be independent of economic or technological advancement. The poor cognitive functioning among school-aged HIV-positive children may be explained by the direct effects of HIV on neurodevelopment during the first few years of life, and by the indirect effect through recurrent opportunistic infections. It was also noted that 56% (56 of 100) perinatally HIV-infected children had cognitive performance at average and above-average intelligence, which is at variance with findings of previous studies. [20, 23] The better cognitive performance reported in the index study may be owing to the fact that most of the subjects were on highly active antiretroviral therapy (HAART) and it has been documented that HAART may halt or possibly reverse progression of HIV-associated encephalopathy.
Lower cognitive function was seen with worsening WHO clinical staging and immune suppression. These findings agree with previous studies. [12, 24, 25] This suggests that early diagnosis and treatment of HIV may delay the cognitive deficit associated with HIV. Antiretroviral therapy may prevent CNS manifestation of HIV infection and reverse the process in children with established HIV encephalopathy, although not completely because there are residual features of arrested HIV encephalopathy. [26] In the index study, children from lower socioeconomic class were about three times more likely to have below-average intelligence. It has been speculated that children from families of low socioeconomic status are more likely to live in less stimulating and supportive home environments. [27] Therefore, HIV-infected children of low socioeconomic status should especially be targeted for support.
C O N C L U S I O N S
The neurocognitive function of school-aged HIV-infected Nigerian children was significantly lower than those of HIV-negative controls matched for age and sex. Cognitive functions worsened with severity of immunosuppression, lower socio-economic status and lower maternal educational attainment.
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